Literature DB >> 5032785

Successful use of oral diazoxide in the treatment of severe toxaemia of pregnancy.

J E Pohl, H Thurston, D Davis, M Y Morgan.   

Abstract

Treatment with oral diazoxide for periods of 4 to 10 weeks in hospital allowed adequate control of hypertension with continuation of fetal growth in four patients with severe toxaemia. Two were insulin-dependent diabetics and one of these suffered from renal failure. In all patients albuminuria diminished markedly, while the fluid retention was controlled with frusemide. Three pregnancies were successfully terminated by lower segment caesarean section and in the remaining case vaginal delivery resulted in the birth of a healthy baby. Control of blood sugars presented no problems in the diabetic patients. Only minimal adjustments of insulin dosage were required. One of the non-diabetic patients developed mild hyperglycaemia which responded to tolbutamide. The babies, ranging in age from 5 to 12 months, have continued to thrive.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5032785      PMCID: PMC1788130          DOI: 10.1136/bmj.2.5813.568

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  14 in total

1.  Effective circulation of the uterine wall in late pregnancy measured with 24NaCl.

Authors:  N MORRIS; S B OSBORN; H P WRIGHT
Journal:  Lancet       Date:  1955-02-12       Impact factor: 79.321

2.  Fetal mortality in essential hypertension.

Authors:  R LANDESMAN; E HOLZE; L SCHERR
Journal:  Obstet Gynecol       Date:  1955-10       Impact factor: 7.661

3.  [Diazoxide experimentally exercises an inhibitory action on the basal secretion of insulin].

Authors:  A Loubatières; R Alric; M M Mariani; H de Malbosc; G Ribes
Journal:  C R Seances Soc Biol Fil       Date:  1966

4.  [Actions of diazoxide on the cardiovascular system, on the metabolism of the myocardium and on sympathetic discharges].

Authors:  H Schmitt; M Laubie
Journal:  Arch Int Pharmacodyn Ther       Date:  1968-02

5.  Clinical use of diazoxide and mechanism for its hyperglycemic effects.

Authors:  A L Graber; D Porte; R H Williams
Journal:  Diabetes       Date:  1966-03       Impact factor: 9.461

Review 6.  Diazoxide and the treatment of hypoglycemia: an historical review.

Authors:  J Black
Journal:  Ann N Y Acad Sci       Date:  1968-04-11       Impact factor: 5.691

7.  The dntidiuretic action of diazoxide.

Authors:  J E Pohl; H Thurston; J D Swales
Journal:  Clin Sci       Date:  1972-02       Impact factor: 6.124

8.  Some effects of the hypotensive drug diazoxide on the cardiovascular system.

Authors:  W G Nayler; I McInnes; J B Swann; D Race; V Carson; T E Lowe
Journal:  Am Heart J       Date:  1968-02       Impact factor: 4.749

9.  The long term effect of repeated acute reductions of arterial pressure with diazoxide in patients with severe hypertension.

Authors:  F A Finnerty; N Kakaviatos; M Davidov
Journal:  Ann N Y Acad Sci       Date:  1968-04-11       Impact factor: 5.691

10.  Use of diazoxide in hypertension with renal failure.

Authors:  J E Pohl; H Thurston
Journal:  Br Med J       Date:  1971-10-16
View more
  7 in total

1.  Effects of fetal exposure to diazoxide in man.

Authors:  R D Milner; S K Chouksey
Journal:  Arch Dis Child       Date:  1972-08       Impact factor: 3.791

2.  Dangers of diazoxide.

Authors:  J E Pohl; H Thurston
Journal:  Br Med J       Date:  1972-11-25

3.  Dangers of diazoxide.

Authors:  M S Knapp; R Cove-Smith; G Hall; M McIllmurray
Journal:  Br Med J       Date:  1972-10-28

4.  Diazoxide in treatment of primary pulmonary hypertension.

Authors:  S W Wang; J E Pohl; D J Rowlands; E G Wade
Journal:  Br Heart J       Date:  1978-05

5.  [Comparison of oral diazoxide and minoxidil in refractory hypertension].

Authors:  A Meier; P Weidmann; Z Glück; G Keusch; M Grimm; I Minder; F C Reubi
Journal:  Klin Wochenschr       Date:  1980-07-01

6.  Development of extrapyramidal symptoms in hypertensive patients treated with diazoxide.

Authors:  D Neary; H Thurston; J E Pohl
Journal:  Br Med J       Date:  1973-09-01

7.  Clinical and haemodynamic effects of diazoxide in primary pulmonary hypertension.

Authors:  M Honey; L Cotter; N Davies; D Denison
Journal:  Thorax       Date:  1980-04       Impact factor: 9.139

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.